Teva Pharmaceutical Industries has launched the generic Vytorin (ezetimibe and simvastatin) tablets in the US.
Subscribe to our email newsletter
Ezetimibe and simvastatin tablets are a prescription medicine that contains two cholesterol lowering medicines, ezetimibe and simvastatin, which are used along with diet to:
- Lower the level of “bad” cholesterol (low density lipoprotein cholesterol or LDL)
- Increase the level of “good” cholesterol (high density lipoprotein cholesterol or HDL)
- Lower the level of fat in blood (triglycerides)
Ezetimibe and simvastatin tablets further enhance Teva’s statin portfolio. With nearly 600 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S.
Currently, one in six generic prescriptions dispensed in the U.S. is filled with a Teva product.
Vytorin had annual sales of approximately $678 million in the U.S. according to IMS data as of February 2017.